Insider · CIK 0001913765
Gina Mazzariello
Files at AMLX (Amylyx Pharmaceuticals, Inc.). First filing Feb 5, 2025, latest Sep 14, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AMLX: Amylyx Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | Amylyx Pharmaceuticals, Inc. | $310k 9,536 shares | -5% | +182% from low-19% from high | |
| 13Weak | Amylyx Pharmaceuticals, Inc. | $246k 30,000 shares | -16% | +229% from low-3% from high | |
| 35Weak | Amylyx Pharmaceuticals, Inc. | $32k 9,192 shares | -5% | +42% from low-50% from high | |
| 30Weak | Amylyx Pharmaceuticals, Inc. | $5,022 1,611 shares | -1% | +20% from low-57% from high | |
| 30Weak | Amylyx Pharmaceuticals, Inc. | $13k 4,169 shares | -3% | +20% from low-57% from high | |
| 30Weak | Amylyx Pharmaceuticals, Inc. | $13k 3,678 shares | -3% | +37% from low-51% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -9,525 | $32.46 | $309k | 190,849 | 28 d ago |
| Sep 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -11 | $33.34 | $367 | 190,838 | 28 d ago |
| Aug 12, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -15,000 | $8.07 | $121k | 171,969 | Aug 14, 2025 |
| Aug 13, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -15,000 | $8.34 | $125k | 156,969 | Aug 14, 2025 |
| May 22, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | GGift Common Stock | -1,000 | $0.00 | $0 | 186,969 | May 27, 2025 |
| Mar 31, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -9,192 | $3.48 | $32k | 187,969 | Apr 2, 2025 |
| Mar 6, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | AGrant or award Common Stock | +63,851 | $0.00 | $0 | 197,161 | Mar 10, 2025 |
| Mar 6, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +95,777 | $0.00 | $0 | 95,777 | Mar 10, 2025 |
| Mar 3, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -1,611 | $3.12 | $5,022 | 133,310 | Mar 5, 2025 |
| Feb 24, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -4,169 | $3.15 | $13k | 134,921 | Feb 26, 2025 |
| Feb 3, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -3,678 | $3.49 | $13k | 139,090 | Feb 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.